Logo

Third Wave Extends Invader Contract With Japanese Reference Lab BML

Jan 08, 2004

NEW YORK, Jan. 8 (GenomeWeb News) - Third Wave Technologies has extended its multi-year partnership with BML, a Tokyo-based clinical reference lab, by at least one year, Third Wave said today.

The companies will continue their collaboration, begun in December 2000, to use Third Wave's Invader technology to develop and commercialize molecular diagnostic tests for infectious diseases.

The original agreement the agreement called for BML to pay Third Wave $3 million up front, and provide $4 million in funding for Invader product development over the next three years. In exchange, Third Wave retained the right to market and sell any products developed under the agreement outside Japan, and will later acquire rights to develop and market these products inside Japan.

Breaking News
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.